by support | Oct 16, 2025 | Blogs
MAC is NTM: Understanding the Connection Between These Two Terms Many patients newly diagnosed with a mycobacterial lung infection are often confused by the terminology used. You may have heard your doctor mention “MAC” or “NTM” — sometimes interchangeably — and...
by support | Aug 12, 2025 | Blogs
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis August 12, 2025 marks a new chapter in care for patients worldwide Tuesday, August 12, 2025, is a monumental day for the bronchiectasis community. The U.S. Food and Drug Administration...
by support | Jul 21, 2025 | Blogs
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support Every year on August 4th, we come together to recognize World NTM Awareness Day, a global movement dedicated to raising awareness about nontuberculous mycobacterial (NTM) lung...
by support | Jul 21, 2025 | Blogs
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference Held May 14–15 in Berkeley, California and Online The 2025 NTM & Bronchiectasis Patient Conference brought together patients, caregivers, clinicians, and researchers...
by support | May 7, 2025 | Blogs
Supporting Mental Health for the NTM Community: Mental Health Awareness Month May is Mental Health Awareness Month, a time to shine a light on the importance of emotional well-being — especially for those living with chronic illnesses like NTM (nontuberculous...
